Amryt Pharma Plc

Amryt Pharma (AMYT)

Company name:Amryt Pharma Plc
EPIC:AMYTTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BKLTQ412
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.amrytpharma.com/Description:ORD 6P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 121.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 118.00 125.00 121.50 121.50 121.50 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 263.46 216.84 0.01 -8.02 - - - 141.00 - 12.00

Amryt Pharma Key Figures

(at previous day's close)
Market Cap.263.46m
Shares In Issue216.84m
Prev. Close121.50
PE Ratio- 
Dividend Yield-%
EPS - basic-8.02p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-5.42p
Return On Equity (ROE)-%
Operating Margin-178.09%
PEG Factor- 
EPS Growth Rate19.97%
Dividends PS Growth Rate-%
Net Debt57.61m
Gross Gearing104.57%
Quick Assets13.48m
Net Working Capital5.69m
Intangibles / Fixed Assets97.97%
Turnover PS5.99p
Pre-Tax Profit PS-10.67p
Retained Profit PS-10.69p
Cash PS4.07p
Net Cash PS-0.30p
Net Tangible Asset Value PS *-23.19p
Net Asset Value PS-1.34p
Spread7.00 (5.60%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Amryt Pharma Balance Sheet

LSE:AMYT:Liabilities+EQLSE:AMYT:Assets

Share Price Performance

Sample Period †HighLow
1 week125.00118.00
4 weeks125.00112.00
12 weeks141.0092.50
1 year141.0012.00

Share Price Chart (5 years)

Amryt Pharma Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week122.50-1.00-0.82118.000.05119.00
4 weeks116.505.004.29112.000.19119.53
12 weeks92.5029.0031.3592.500.11118.06
26 weeks12.75108.75852.9412.380.11117.55
1 year12.50109.00872.0012.000.1541.24
3 years14.50107.00737.9312.000.2422.88
5 years25.0096.50386.0012.000.2322.24
† periods calculated are whole weeks rather than calendar months

Amryt Pharma Key Management Ratios

Amryt Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 3.50 
Tobin's Q Ratio (excl. intangibles)11.60 
Dividend Yield-%
Market-to-Book Ratio-90.68 
Price-to-Pre-Tax Profit PS-11.38 
Price-to-Retained Profit PS-11.37 
Price-to-Cash Flow PS-22.42 
Price-to-Sales PS20.27 
Price-to-Net Tangible Asset Value PS-5.24 
Price-to-Cash PS29.86 
Net Working Capital PS2.63 
Price Pct to Working Capital PS46.26%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Amryt Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio105.37%
Debt-to-Equity Ratio-19.61 
Debt-to-Equity Ratio (excl. Intgbl)-1.13 
Debt-to-Equity Market Value0.22 
Net Gearing90.69%
Net Gearing (excl. Intangibles)356.94%
Gross Gearing104.57%
Gross Gearing (excl. Intangibles)411.60%
Gearing Under 1 Year14.90%
Gearing Under 1 Year (excl. Intgbl)58.64%
Assets/Equity-21.86 
Cash/Equity-303.65 
(Liquidity Ratios)
Net Working Capital to Total Assets8.96%
Current Ratio1.60 
Quick Ratio (Acid Test)1.42 
Liquidity Ratio0.93 
Cash & Equiv/Current Assets58.20%
(Solvency Ratios)
Enterprise Value311.60m
CFO/Sales-0.90 
CFO/Attributable Profit- 
CFO/Assets-0.18 
CFO/Debt-0.18 
Total Debt/Equity Market Value0.25 
Total Debt/Sales5.11 
Total Debt/Pre-Tax Profit-2.87 
Total Debt66.43m
Total Debt/Net Current Assets11.66%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
0.01190.0025

Amryt Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-42.82%
Return On Assets (ROA)-30.75%
Net Profit Margin-178.34%
Assets Turnover0.17 
Return On Equity (ROE)-%
Return On Investment (ROI)-35.55%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-178.34%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.39 
Fixed Assets Turnover0.24 
Current Assets Turnover0.60 
Net Working Capital Turnover 
Inventory Turnover8.81 
(Other Operating Ratios)
Total Assets-to-Sales5.80 
Debtors-to-Sales38.12%
Debt Collection Period139.12Days

Amryt Pharma Dividends

Sorry No Data Available

Amryt Pharma Fundamentals
 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
turnover--1.35100.00%12.78100.00%14.45100.00%m
pre tax profit-1.31--7.80-577.65%-26.14-204.54%-25.74-178.09%m
attributable profit-1.17--7.80-577.65%-26.11-204.37%-25.78-178.34%m
retained profit-1.17--7.80-577.65%-26.11-204.37%-25.78-178.34%m
eps - basic-5.75 -4.78 -11.72 -9.38 
eps - diluted-5.75 -4.78 -11.72 -9.38 
dividends per share- - - - 

Amryt Pharma Balance Sheet

 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
LSE:AMYT:Liabilities+EQLSE:AMYT:AssetsLSE:AMYT:Liabilities+EQLSE:AMYT:AssetsLSE:AMYT:Liabilities+EQLSE:AMYT:AssetsLSE:AMYT:Liabilities+EQLSE:AMYT:Assets
 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
ASSETS
fixed assets fixed assets--%1.181.81%1.161.45%0.961.36%m
intangibles intangibles--%52.5280.45%52.6165.68%52.7074.59%m
fixed investments fixed investments--%--%--%0.130.18%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%0.771.18%1.081.35%1.872.64%m
debtors debtors0.282.19%2.543.89%4.735.90%5.187.33%m
cash & securities cash & securities12.6397.81%8.2712.67%20.5125.61%9.8113.89%m
TOTAL12.91100%65.29100%80.09100%70.64100%m
LIABILITIES
creditors - short creditors - short0.453.48%3.555.44%9.8012.23%10.5314.90%m
creditors - long creditors - long--%28.7043.96%48.4160.44%63.3589.67%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.453.48%32.2549.40%58.2072.67%73.87104.57%m
EQUITY
ord cap, reserves ord cap, reserves12.4696.52%33.0450.60%21.8927.33%-3.23-4.57%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL12.4696.52%33.0450.60%21.8927.33%-3.23-4.57%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Amryt Pharma Cash Flow Statement

31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
Operating CF-1.47-6.11-11.86-13.07m
Pre-Financing CF-2.38-3.65-12.18-13.28m
Retained CF-2.588.1012.24-10.70m

Amryt Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191119 10:52:17